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In pancreatic -cells, glucose causes a rapid increase
in the rate of protein synthesis. However, the mecha-
nism by which this occurs is poorly understood. In this
report, we demonstrate, in the pancreatic -cell line
MIN6, that glucose stimulates the recruitment of ribo-
somes onto the mRNA, indicative of an increase in the
rate of the initiation step of protein synthesis. This in-
crease in the rate of initiation is not mediated through
an increase in the availability of the initiation complex
eIF4F, because glucose is unable to stimulate eIF4F as-
sembly or, in the absence of amino acids, modulate the
phosphorylation status of 4E-BP1. Moreover, in MIN6
cells and isolated islets of Langerhans, rapamycin, an
inhibitor of the mammalian target of rapamycin, only
partially inhibited glucose-stimulated protein synthe-
sis. However, we show that glucose stimulates the de-
phosphorylation of eIF2 in MIN6 cells and the assem-
bly of the translational ternary complex, eIF2-GTPMet-
tRNAi, in both MIN6 cells and islets of Langerhans. The
changes in the phosphorylation of eIF2 are not medi-
ated by the PKR-like endoplasmic reticulum eIF2 ki-
nase (PERK), because PERK is not phosphorylated at
low glucose concentrations and overexpression of a
dominant negative form of PERK has no significant ef-
fect on either glucose-stimulated protein synthesis or
the phosphorylation of eIF2. Taken together, these re-
sults indicate that glucose-stimulated protein synthesis
in pancreatic -cells is regulated by a mechanism
largely independent of the activity of mammalian target
of rapamycin, but which is likely to be dependent on the
availability of the translational ternary complex, regu-
lated by the phosphorylation status of eIF2.
The pancreatic -cell releases insulin in response to glucose.
Additionally, there is a rapid 2-fold increase in total protein
synthesis, a 20-fold increase in proinsulin synthesis, and a
co-ordinate increase in the synthesis of a small subset of pro-
teins, including the prohormone convertases PC2 and PC3
(1–9). These rapid increases in protein synthesis are almost
entirely mediated at the translational level (1–4, 6, 7, 10) and
ensure the replenishment of secreted proteins and the mainte-
nance of -cell mass. However, the mechanism by which glu-
cose regulates protein synthesis in pancreatic -cells is poorly
understood.
One key step in the regulation of protein synthesis is the
recruitment of the 40 S ribosome to the mRNA. This is pro-
moted by the initiation complex, eIF4F,1 composed of the ini-
tiation factors eIF4G, a large scaffolding protein, eIF4E, the
protein that binds to the 5-cap structure (7mGTP) of the
mRNA, and eIF4A, an RNA helicase (11). An important mech-
anism regulating eIF4F assembly involves a family of eIF4E-
binding proteins (4E-BPs, archetype 4E-BP1) (12, 13). In their
hypophosphorylated forms, 4E-BP1 competes with eIF4G for
binding to eIF4E and can therefore inhibit eIF4F complex
formation. Phosphorylation of 4E-BP1 leads to its dissociation
from eIF4E, therefore allowing eIF4E to bind eIF4G, poten-
tially leading to an increase in mRNA translation (14–16). In
islets and in the pancreatic -cell lines RINm5F and TC6-F7,
glucose can, in synergy with amino acids and insulin released
into the medium, increase the phosphorylation of 4E-BP1 (9),
indicating that the regulation of eIF4F assembly may be im-
portant in glucose-stimulated protein synthesis. However, in
islets, glucose can stimulate protein synthesis in the absence of
amino acids (17–19), under conditions that do not lead to the
dissociation of 4E-BP1 from eIF4E (20), a step considered a
prerequisite for eIF4F assembly.
Another important rate-limiting step in the regulation of
protein synthesis is the binding of the methionyl-initiator
tRNA (Met-tRNAi) to the 40 S ribosomal subunit, regulated by
the availability of the translational ternary complex (eIF2-
GTPMet-tRNAi), consisting of the heterotrimeric eukaryotic
initiation factor 2 (eIF2), GTP, and Met-tRNAi (21). The bind-
ing of the Met-tRNAi to the 40 S ribosomal subunit is depend-
ent on the formation of the translational ternary complex that
assembles only when eIF2 is in its GTP-bound state (21, 22).
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initiation factors (including the eIF4F complex), delivers the
eIF2-GTP-bound Met-tRNAi to the AUG start codon. This is
followed by the joining of the 60 S ribosomal subunit, leading to
the formation of the 80 S ribosome. The GTP bound to eIF2 is
then hydrolyzed to GDP and Pi, yielding the inactive eIF2GDP
complex, which is unable to bind Met-tRNAi. The recycling of
the inactive eIF2GDP complex to the active eIF2GTP complex
is catalyzed by the guanine nucleotide exchange factor, eIF2B
(21, 23). eIF2B plays a crucial role in ternary complex forma-
tion and is regulated in response to a wide range of conditions
by several mechanisms, including phosphorylation, allosteric
regulation, and competitive inhibition by the phosphorylated
form of the -subunit of eIF2 (eIF2) (21). Interestingly, eIF2B
activity is transiently up-regulated in isolated islets of Lange-
rhans in response to glucose (20). Therefore, glucose may be an
important modulator of ternary complex formation and hence
protein synthesis in pancreatic -cells.
Competitive inhibition of eIF2B by the phosphorylated form
of eIF2 is the most studied and best characterized example by
which eIF2B activity is modulated. Several eIF2 kinases have
been identified in mammals: the double-stranded RNA-depend-
ent eIF2 kinase (PKR), the mammalian orthologue of the yeast
GCN2 protein kinase (mGCN2), the heme-regulated eIF2 ki-
nase (HRI), and the eIF2 kinase-like endoplasmic reticulum
kinase (PERK). These kinases respond to different physiologi-
cal stimuli. For example, PKR is induced by interferon and
regulated by double-stranded RNA (24, 25). (m)GCN2 is acti-
vated under conditions of amino acid and glucose starvation
(21, 26, 27). HRI is regulated by heme in erythroid cells (28).
PERK is highly expressed in the pancreas and is activated by
endoplasmic reticulum stress (29–31). Interestingly, PERK
plays an important role in pancreatic -cell survival, because
PERK knock-out mice develop diabetes mellitus due to the loss
of pancreatic -cells (32). Additionally, islets isolated from pre-
diabetic PERK knock-out mice have increased glucose-stimu-
lated proinsulin synthesis (32), indicating that eIF2 phospho-
rylation may play a role in the specific regulation of proinsulin
synthesis.
In this report, we demonstrate that glucose-stimulated pro-
tein synthesis in pancreatic -cells is accompanied by an in-
crease in the rate of initiation. This increase is not mediated
through an increase in the assembly of the eIF4F complex and
is only partially dependent on the activity of mTOR. However,
we show that glucose stimulates an increase in the availability
of the translational ternary complex and the dephosphorylation
of eIF2. Therefore, taken together, glucose-stimulated protein
synthesis in pancreatic -cells is likely the result of an increase
in the rate of initiation mediated through an increase in the
availability of the translational ternary complex, brought about
by the dephosphorylation of eIF2.
EXPERIMENTAL PROCEDURES
Chemicals and Materials—Rapamycin was purchased from Calbio-
chem. m7GTP-Sepharose and RNAguardTM were from Amersham Bio-
sciences. Dulbecco’s modified Eagle’s medium without glucose (DMEM)
and fetal calf serum were obtained from Invitrogen. All other chemicals
(unless stated) were obtained from Sigma.
Cell Culture and Treatment—In this study, MIN6 cells (kindly pro-
vided by Prof. Jun-Ichi Miyazaki) were used between passages 16 and
35 at80% confluence. MIN6 cells were grown in DMEM containing 25
mM glucose (DMEM full media) supplemented with 15% heat-inacti-
vated fetal calf serum, 100 g/ml streptomycin, 100 units/ml penicillin
sulfate, and 75 M -mercaptoethanol, equilibrated with 5% CO2, 95%
air at 37 °C. Prior to treatment, the medium was removed and the cells
washed twice with either HEPES-balanced Krebs-Ringer bicarbonate
buffer (115 mM NaCl, 5 mM KCl, 10 mM NaHCO3, 2.5 mM MgCl2, 2.5 mM
CaCl2, 20 mM HEPES, pH 7.4) containing 0.5% bovine serum albumin
(KRB buffer) or DMEM minus glucose (DMEM). The cells were then
incubated for 1 h at 37 °C in KRB buffer or DMEM containing 2 mM
glucose (unless otherwise stated) prior to incubation in KRB buffer or
DMEM containing 2 or 20 mM glucose for a further hour (unless other-
wise stated). Full details of treatments are provided in the figure
legends. After treatment, cells were washed twice in ice-cold phosphate-
buffered saline, and the cells were lysed by the addition of ice-cold lysis
buffer containing 1% Triton X-100, 10 mM -glycerophosphate, 50 mM
Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM EGTA, 1 mM sodium orthovana-
date, 1 mM benzamidine-HCl, 0.2 mM phenylmethylsulfonyl fluoride, 1
g/ml each of leupeptin and pepstatin, 0.1% -mercaptoethanol, and 50
mM sodium fluoride. The lysates were then centrifuged for 10 min at
16,000  g. The supernatants were kept, and total protein concentra-
tions were determined by the Bradford assay (Bio-Rad) using bovine
serum albumin as standard. The protein lysates were stored at 80 °C
until further analysis.
Sedimentation Gradients and Polysome Analysis—MIN6 cells were
incubated for 1 h in either KRB or DMEM supplemented with 2 mM
glucose prior to the cells being incubated for a further 1 h in either KRB
or DMEM supplemented with either 2 or 20 mM glucose. Cycloheximide
was added for the last 5 min to a final concentration of 0.1 mg/ml. After
treatment, the cells were scraped into polysome extraction buffer (1%
Triton X-100, 20 mM HEPES, pH 7.6, 2 mM MgCl2, 130 mM KCl, 1 mg/ml
heparin, 1 mg/ml cycloheximide, 1 mM dithiothreitol, 1 l/ml RNA-
guard) and lysed using 15 strokes of a potter homogenizer. Cell lysates
were centrifuged for 10 min at 13,000  g at 4 °C to remove nuclei and
cellular debris. The supernatants were then layered onto 7–47% su-
crose gradients (sucrose, 20 mM HEPES, pH 7.6, 2 mM MgCl2, 130 mM
KCl, 1 mg/ml heparin, 1 mg/ml cyclohexamide, 1 mM dithiothreitol) and
centrifuged for 2 h at 39,000 rpm at 4 °C in a TH64.1 rotor (Sorvall).
The gradients were pumped, by upward displacement, through a UV
monitor, and the absorbance was read at 254 nm using an ISCO gra-
dient collector.
Islet Isolation and Culturing—Pancreatic islets were isolated from
200- to 250-g female Wistar rats by collagenase digestion and His-
topaque density gradient centrifugation as previously described (3).
Islets were either used immediately or were cultured in RPMI 1640
containing 5.6 mM glucose with 10% heat-inactivated fetal calf serum,
100 units/ml penicillin, and 100 g/ml streptomycin (see figure legends
for details). Prior to treatment, islets were washed twice with either
KRB buffer or DMEM minus glucose. The cells were then incubated for
2 h at 37 °C in KRB buffer or DMEM containing 2 mM glucose prior to
incubation in KRB buffer or DMEM containing 2 or 20 mM glucose for
the times indicated in the figure legends (full details of treatments are
provided in the figure legends). After treatment, islets were collected by
centrifugation for 1 min at 16,000  g and lysed by the addition of
ice-cold lysis buffer.
Adenovirus Generation and Adenoviral Infection—cDNA encoding
the firefly luciferase reporter downstream of the 5-UTR of ATF4
and cDNA encoding amino acids 1–583 of PERK (PERKC) were
subcloned from the plasmids TK::ATF4UTR::LUC (30) and
PERK.WT.9E10.pCDNA.amp (29), respectively, kindly provided by
Prof. David Ron (Skirball Institute, New York University School of
Medicine), into the shuttle vector pAd-Track-CMV prior to the genera-
tion of recombinant adenoviruses. Recombinant adenoviruses express-
ing ATF4 luciferase (Ad-ATF4luc) and PERKC (Ad-PERKC) were
then prepared using the Ad-easy system (33) as previously described
(34). The adenoviral and shuttle vectors were provided by Prof. Tong-
Chuan He, Howard Hughes Medical Institute & Johns Hopkins Oncol-
ogy Center. Recombinant adenoviruses containing EGFP (Ad-
emptyEGFP) were a gift from Dr. Jo Carter (University of Leicester).
To infect MIN6 cells or islets of Langerhans, the recombinant adeno-
viruses were mixed with culture medium, and cells were exposed to the
viruses with a 100–200 multiplicity of infection for 24–48 h prior to the
experiment. Under these conditions, 90% of cells were infected, as
determined by EGFP expression.
Protein Synthesis Measurements—Protein synthesis measurements
were performed as described previously (35). In these experiments, the
cell treatments were performed in the presence of [35S]methionine for
1 h. All treatments were stopped by washing the cells with ice-cold
phosphate-buffered saline and lysing them in ice-cold extraction buffer
(as described under “Cell Culture and Treatment”). Cell lysates were
prepared, and equal amounts of protein (about 20 g) were spotted onto
3MM Whatman filters. The filters were then washed by boiling them for
1 min in 5% trichloroacetic acid containing 0.1g/liter methionine. This
was repeated three times. The filters were then dried and immersed in
scintillant before determining radioactivity by scintillation counting.
SDS-PAGE, Western Blotting, and Immunoprecipitation—SDS-
PAGE and Western blotting were performed as described previously
(35). The anti-eIF2, anti-4E-BP1, anti-eIF4G1, anti-eIF4A, and anti-
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poly(A)-binding protein (PABP) antibodies were generous gifts from
Chris Proud (Dundee University), Adri Thomas (Utrecht University),
Simon Morley (Sussex University), H. Trachsel (Bern University), and
Amelia Nieto (Centro Nacional de Biotecnologı´a Cantoblanco, Madrid),
respectively. Anti-phospho (Ser-65 and Thr-36/45) 4E-BP1, anti-eIF4E,
anti-phospho (Thr-980) PERK, anti-phospho (Ser-235/236) ribosomal
protein S6 and anti-Erk2 antisera were purchased from New England
Biolabs. Anti-luciferase antiserum was purchased from Chemicon. An-
ti-phospho (Ser-51) eIF2was purchased from Biosource. Detection was
by horseradish peroxidase-linked anti-rabbit/mouse secondary antibod-
ies and enhanced chemiluminescence (Amersham Biosciences). Briefly,
immunoprecipitations of luciferase were performed as follows. Anti-
luciferase antibody was coupled to Protein G-Sepharose for 1 h at room
temperature. The bound antibody/protein G complexes were then added
to [35S]methionine-labeled MIN6 protein lysates and rotated for 2 h at
4 °C. The beads were then washed three times in radioimmune precip-
itation assay buffer, and the bound proteins were finally eluted into
Laemmli sample buffer (36) prior to being separated by SDS-PAGE.
The [35S]methionine-labeled luciferase was then visualized by
autoradiography.
m7GTP-Sepharose Chromatography—m7GTP-Sepharose chromatog-
raphy was performed as described previously (37). Briefly, equal
amounts of protein (0.3–0.4 mg) were incubated with 30 l of m7GTP-
Sepharose CL-6B for 1 h at 4 °C. The beads were then washed three
times in lysis buffer, and the bound proteins were separated on a 12.5%
SDS-polyacrylamide gel and visualized by immunoblotting using anti-
sera against eIF4E, eIF4G1, 4E-BP1, eIF4A, and PABP.
RESULTS
Glucose-stimulated Protein Synthesis Is Mediated through
an Increase in the Rate of Initiation—To investigate the mech-
anism by which glucose regulates protein synthesis in pancre-
atic -cells, we initially determined the rates of protein synthe-
sis at either low or high glucose concentrations in the
pancreatic -cell line MIN6, a cell line that synthesizes and
secretes insulin in response to physiologically relevant glucose
concentrations (6, 38).
MIN6 cells were preincubated for 1 h in either KRB or
DMEM (i.e. in the absence or presence of amino acids) contain-
ing 2 mM glucose and then further incubated for 1 h at either 2
or 20 mM glucose in the presence or absence of the transcrip-
tional inhibitor actinomycin-D. Increasing glucose concentra-
tion from 2 to 20 mM led to a significant increase in [35S]me-
thionine incorporation into total protein in cells incubated in
either KRB or DMEM. These increases were unaffected by the
addition of actinomycin-D, demonstrating that glucose-stimu-
lated protein synthesis is mediated by a post-transcriptional
mechanism (Fig. 1). These results are in agreement with and
extend previous findings in MIN6 cells (6).
To establish which step in protein synthesis may be impor-
tant in glucose-stimulated protein synthesis, we determined
the polysome profile of MIN6 cells incubated at both 2 and 20
mM glucose in either KRB or DMEM (Fig. 2). In cells incubated
in either KRB or DMEM, increasing glucose concentration from
2 to 20 mM led to a decrease in the 80 S monosomal peak along
with an increase in the number of polysomes, indicative of an
increase in the rate of the initiation phase of protein synthesis.
Additionally, the polysome to monosome ratio at either low or
high glucose concentrations is greater when cells are incubated
in DMEM compared with those incubated in KRB. This indi-
cates that the basal rates of protein synthesis are higher in
cells incubated in DMEM than those incubated in KRB.
The Role of mTOR in Glucose-stimulated Protein Synthesis
in MIN6 Cells—Amino acids and glucose have been shown to
influence the rate of protein synthesis in a number of cell types
through the modulation of the phosphorylation status of 4E-
BP1 and p70 S6 kinase via a mechanism that is dependent on
mTOR. We therefore investigated the role of mTOR in glucose-
stimulated protein synthesis in MIN6 cells. MIN6 cells were
preincubated for 1 h in either KRB or DMEM supplemented
with 2 mM glucose and then further incubated for 1 h in the
same medium (KRB or DMEM) at either 2 mM or 20 mM glucose
in the presence or absence of rapamycin, a specific inhibitor of
mTOR (Fig. 3). Increasing glucose concentration in cells incu-
bated in KRB (i.e. in the absence of amino acids) had no effect
on the phosphorylation of either p70 S6 kinase or 4E-BP1 as
assessed by determining: 1) the mobility of both 4E-BP1 and
p70 S6 kinase on SDS-PAGE; 2) the phosphorylation of specific
residues within 4E-BP1, Thr-36/45 and Ser-65; and 3) the
phosphorylation of ribosomal protein S6, a substrate for p70 S6
kinase (Fig. 3a). In contrast, in MIN6 cells incubated in
DMEM, an increase in glucose concentration led to: 1) an
increase in the phosphorylation of both 4E-BP1 and p70 S6
kinase, demonstrated by their decrease in mobility on SDS-
PAGE; 2) the phosphorylation of residues Thr-36/45 and Ser-65
within 4E-BP1; and 3) an increase in the phosphorylation of
ribosomal protein S6 at Ser-235/236 (Fig. 3a). In this latter
condition (i.e. in the presence of amino acids), rapamycin com-
pletely blocked both the basal and glucose-stimulated phospho-
rylation of p70 S6 kinase, 4E-BP1, and S6, indicating that
mTOR plays an important role in these events (Fig. 3a). In-
deed, it has been previously demonstrated that amino acids are
required for glucose-stimulated phosphorylation of down-
stream targets of mTOR in the pancreatic -cell line RINm5F
cells and in islets (39), and this explains why glucose cannot
stimulate the phosphorylation of the downstream targets of
mTOR in KRB.
Because the phosphorylation of 4E-BP1 can lead to its re-
lease from eIF4E, an increase in eIF4F complex assembly (i.e.
an increase in the association of eIF4G and eIF4A with eIF4E)
and hence the rate of initiation, we therefore examined the
effect of glucose on eIF4F assembly by pulling down eIF4E and
associated proteins using 7mGTP-Sepharose beads (Fig. 3b). In
KRB (i.e. in the absence of amino acids), an increase in glucose
concentration from 2 to 20 mM had no detectable effect on the
dissociation of 4E-BP1 from eIF4E, on eIF4F assembly, or on
the association of PABP with the eIF4F complex. Additionally,
treatment of cells with rapamycin had no significant effect on
glucose-stimulated protein synthesis in KRB (Fig. 3c). There-
fore, the activation of downstream targets of mTOR and the
stimulation of eIF4F assembly play no detectable role in glu-
FIG. 1. Glucose regulation of protein synthesis in the pancre-
atic -cell line, MIN6. MIN6 cells were preincubated for 1 h in KRB
or DMEM supplemented with 2 mM glucose. The cells were then treated
for 1 h in the same medium, KRB or DMEM, containing either 2 or 20
mM (2 or 20) glucose and [35S]methionine. Where indicated, MIN6 cells
were also incubated in the presence of the transcriptional inhibitor
actinomycin-D (1 g/ml, Act) for the last 30 min of the preincubation
and during the hour treatment. Total protein was precipitated from cell
lysates with trichloroacetic acid (see “Experimental Procedures”), and
the incorporation of [35S]methionine into protein was expressed as the
percentage of control (KRB 2 mM) (n  3  S.D.).
Glucose-stimulated Protein Synthesis 53939
 at K
EELE U
N
IV
ERSITY
 on A
ugust 1, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
cose-stimulated protein synthesis in KRB (i.e. in the absence of
amino acids). In DMEM, basal levels of the eIF4F complex and
the levels of associated PABP were greater than in KRB. An
increase in glucose concentration from 2 to 20 mM in DMEM
caused a moderate release of 4E-BP1 from eIF4E. However,
glucose had no detectable effect on eIF4F assembly or the
association of PABP with the eIF4F complex (Fig. 3b). Treat-
ment of cells with rapamycin led to an increase in the associ-
ation of 4E-BP1 with eIF4E but no dissociation of the eIF4F
complex. Additionally, rapamycin inhibited glucose-stimulated
protein synthesis by only 26% in DMEM (i.e. in the presence of
amino acids) (Fig. 3c). Therefore, the activation of downstream
targets of mTOR and the stimulation of eIF4F assembly is not
the major determinant in glucose-stimulated protein synthesis
in DMEM (i.e. in the presence of amino acids).
Glucose Stimulates the Rapid, Dose-dependent Dephospho-
rylation of eIF2—One important and well characterized mech-
anism by which the initiation of translation and hence protein
synthesis is regulated is via the phosphorylation of the  sub-
unit of eIF2 (eIF2) at Ser-51.
We therefore investigated the phosphorylation of eIF2 in
response to glucose in MIN6 cells. MIN6 cells were preincu-
bated for 1 h in either KRB or DMEM supplemented with 2 mM
glucose and then further incubated for 1 h in the same medium
(i.e. KRB or DMEM) at either 2 or 20 mM glucose (Fig. 4a).
Using a phospho-specific antibody to eIF2 Ser-51, we show
that eIF2 is phosphorylated at low glucose concentration (Fig.
4a). However, at high glucose concentration, eIF2 is dephos-
phorylated (Fig. 4a). The dephosphorylation of eIF2 was
shown to occur between 2 and 10 mM, within the physiological
FIG. 2. Glucose stimulates protein synthesis in MIN6 cells
through an increase in the rate of initiation. Analysis of polysome
profiles from MIN6 cells using sucrose density gradient centrifugation.
MIN6 cells were incubated for 1 h in either KRB (a and b) or DMEM (c
and d) supplemented with 2 mM glucose prior to being incubated in the
same medium, KRB or DMEM, at either 2 or 20 mM glucose for a further
1 h. Cell extracts were layered onto a 7–47% sucrose gradient and
centrifuged at 39,000 rpm for 2 h in a TH64.1 rotor. Gradients were
then fractionated while scanning at 254 nm, and the resulting profiles
are shown. M indicates the position of 80 S monosomes. P indicates the
position of the polysomes. The ratio of polysomes to 80 S monosomes
was determined by measuring the area under the peaks. These results
are representative of at least three separate experiments.
FIG. 3. The role of mTOR in glucose-stimulated protein syn-
thesis. MIN6 cells were preincubated for 1 h in KRB or DMEM sup-
plemented with 2 mM glucose. Where indicated, the cells were also
pre-treated with 200 nM of the mTOR inhibitor rapamycin for the last
30 min. The cells were then incubated for 1 h in the same medium, KRB
or DMEM, containing either 2 or 20 mM glucose and [35S]methionine, in
the presence or absence of 200 nM rapamycin. a, samples of cell lysates
were run on a SDS-polyacrylamide gel followed by Western-blotting
using different antisera; anti-4E-BP1 antibody (4E-BP1); anti-phospho
4E-BP1 (Ser-65) antibody (4E-BP1 P-S65); anti-phospho 4E-BP1 (Thr-
36/45) (4E-BP1 P-T36/45) antibody; anti-p70 S6 kinase antibody (p70
S6 kinase); anti-phospho ribosomal protein S6 (Ser-235/236) antibody
(S6 P-S235/236). b, analysis of proteins isolated by m7GTP-Sepharose
pull-down and separated on a SDS-polyacrylamide gel followed by
Western blotting using antisera against eIF4E, eIF4G1, eIF4A, 4E-
BP1, and PABP. c, incorporation of [35S]methionine into total protein
expressed as percentage of control (KRB 2 mM) (n  3  S.D.). These
results are representative of three separate experiments.
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range of glucose concentrations (Fig. 4b, panel i). Additionally,
decreases in the phosphorylation of eIF2 in response to glu-
cose paralleled increases in the rates of protein synthesis (Fig.
4b, panel ii).
The temporal kinetics of the regulation of eIF2 phosphoryl-
ation in response to glucose were also investigated (Fig. 4c).
Transfer of cells from DMEM complete media containing 25 mM
glucose into KRB supplemented with 2 mM glucose led to the
phosphorylation of eIF2 within 20 min. After a 1-h incubation
in KRB supplemented with 2 mM glucose, the cells were then
further incubated with KRB supplemented with 20 mM glucose.
This led to a rapid (within 15 min) dephosphorylation of eIF2
(Fig. 4c).
Glucose Stimulates the Assembly of the Translational Ter-
nary Complex—A likely consequence of eIF2 dephosphoryl-
ation is an increase in the assembly of the translational ternary
complex via an increase in the activity of eIF2B. To determine
whether ternary complex formation is stimulated by glucose in
vivo, we monitored the expression of luciferase in cells infected
with recombinant adenovirus encoding luciferase downstream
of the 5-UTR of ATF4 and under the control of a cytomegalo-
virus promoter (Ad-ATF4Luc). ATF4 is a transcription factor
whose translation is regulated by short open reading frames in
its 5-UTR by a mechanism analogous to that which regulates
GCN4 expression in yeast (30). Briefly, upon an increase in
ternary complex availability, ATF4 expression is repressed.
However, when the availability of ternary complex is low, ATF4
expression is up-regulated (30).
MIN6 cells were mock infected or infected with the recombi-
nant adenovirus Ad-ATF4Luc. 24 h post-infection, the cells
were preincubated for 1 h in KRB or DMEM supplemented
with 2 mM glucose. The cells were then further incubated for
2 h in the same medium (i.e. KRB or DMEM) at either 2 or 20
mM glucose in the presence of [35S]methionine during the final
hour of treatment. As a positive control, MIN6 cells were
treated with thapsigargin, a compound that induces endoplas-
mic reticulum stress and the phosphorylation of eIF2 via the
activation of PERK (29). eIF2 phosphorylation in turn leads to
a decrease in ternary complex availability. Luciferase was im-
munoprecipitated from the cell lysates and separated by SDS-
PAGE, and the incorporation of [35S]methionine into luciferase
was determined by autoradiography (Fig. 5). As expected, the
incorporation of [35S]methionine into luciferase increased in
cells incubated in the presence of thapsigargin in contrast to
total protein synthesis, which decreased significantly (Fig. 5).
In either KRB or DMEM, the incorporation of [35S]methionine
into luciferase decreased in cells incubated at 20 mM glucose
compared with those incubated at 2 mM glucose, indicative of
an increase in ternary complex availability at high glucose (Fig.
5). This was accompanied by an increase in the incorporation of
[35S]methionine into total protein in cells incubated at 20 mM
glucose compared with those incubated at 2 mM (Fig. 5). We
FIG. 4. Glucose regulates eIF2 phos-
phorylation in MIN6 cells. a, MIN6
cells were preincubated for 1 h in KRB or
DMEM supplemented with 2 mM glucose.
Cells were then incubated in the same
medium (KRB or DMEM) supplemented
with either 2 or 20 mM glucose for a fur-
ther hour. Lysates were separated on
SDS-PAGE and Western-blotted using
anti-phospho eIF2 (Ser-51) (P-eIF2)
and anti-eIF2 (eIF2). The intensities of
the bands were quantified by ImageJ, and
the phosphorylation levels of eIF2 were
normalized to the expression levels of to-
tal eIF2. The results are expressed as a
ratio of eIF2 phosphorylation relative to
eIF2 phosphorylation at low glucose. b,
MIN6 cells were preincubated in KRB
buffer containing no glucose for 1 h, be-
fore incubation in KRB containing the in-
dicated concentrations of glucose for 1 h
in the presence of [35S]methionine. Panel
i, cell lysates were separated on SDS-
polyacrylamide gel and Western blotted
using anti-phospho eIF2 (Ser-51) (P-
eIF2) and anti-eIF2 as a loading con-
trol. The intensities of the bands were
quantified by ImageJ, and the phospho-
rylation levels of eIF2 were normalized
to the expression levels of total eIF2.
The results are expressed as a ratio of
eIF2 phosphorylation relative to eIF2
phosphorylation at low glucose. Panel ii,
incorporation of [35S]methionine into to-
tal protein. Results are indicated as a per-
centage of control (0 mM glucose). (n 3
S.D.). c, MIN6 cells incubated in DMEM
complete media (containing 25 mM glu-
cose) were transferred to KRB buffer sup-
plemented with 2 mM glucose for the time
shown. After 60 min, the cells were then
incubated in KRB supplemented with 20
mM glucose for the times indicated. Cell
lysates were separated on SDS-polyacryl-
amide gel and Western blotted using anti-
phospho eIF2 (Ser-51) (P-eIF2) anti-
body, and as a loading control anti-eIF2
antiserum. These results are representa-
tive of three separate experiments.
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also investigated eIF2 phosphorylation in identical samples
used to investigate changes in ternary complex formation using
a phospho-specific antibody to eIF2 Ser-51 (Fig. 5). In the
presence of thapsigargin and at low glucose concentrations,
either in the presence or absence of amino acids, eIF2 is
phosphorylated. However, upon an increase in glucose concen-
tration, eIF2 is dephosphorylated. Taken together, these re-
sults indicate that glucose stimulates ternary complex forma-
tion in MIN6 cells incubated in either KRB or DMEM and that
these changes parallel the dephosphorylation of eIF2.
Role of PERK in Glucose-stimulated Protein Synthesis—In
the pancreatic -cell line MIN6, eIF2 phosphorylation is reg-
ulated in response to changes in glucose concentration. At low
glucose concentration (2 mM), eIF2 is phosphorylated,
whereas at high glucose concentration (20 mM), eIF2 is de-
phosphorylated. These changes in the phosphorylation of eIF2
parallel changes in both the rate of protein synthesis and
changes in ternary complex formation. However, the kinase
responsible for the phosphorylation of eIF2 upon glucose dep-
rivation is unknown. One possible candidate is the eIF2 ki-
nase PERK (29, 40).
Upon activation, PERK is auto-phosphorylated at Thr-980.
Therefore, we investigated the phosphorylation status of PERK
in response to glucose in MIN6 cells using a phospho-specific
antibody to PERK (Thr-980). MIN6 cells were preincubated for
1 h in KRB supplemented with 0.5 mM glucose and then further
incubated for 1 h in the same medium at either 0.5 mM glucose,
20 mM glucose, or 20 mM glucose plus thapsigargin as control
(Fig. 6a). As expected, treatment of MIN6 cells with thapsigar-
gin led to a large increase in the phosphorylation of PERK (Fig.
6a). However, no significant change in the phosphorylation of
PERK was detected between low (0.5 mM) and high (20 mM)
glucose concentrations (Fig. 6a).
As a corollary of the above, MIN6 cells were mock infected or
infected with recombinant adenoviruses overexpressing either
a dominant negative mutant of PERK (Ad-PERKC) (29) or
EGFP (Ad-emptyEGFP) only as control. 24 h post-infection, the
cells were incubated in KRB containing 0.5 mM glucose for 1 h
prior to incubation in the same buffer at either 0.5 or 20 mM
glucose for a further 1 h. MIN6 cells were also treated with
thapsigargin as control. Following treatment, the phosphoryl-
ation status of eIF2 (Fig. 6b, panel ii) and the rates of protein
synthesis (Fig. 6b, panel i) were determined. Overexpression of
the dominant negative PERK inhibited thapsigargin induced
eIF2 phosphorylation and blocked a significant proportion of
the inhibitory effect of thapsigargin on the rate of protein
synthesis (Fig. 6b). However, expression of the dominant neg-
ative PERK had only a partial effect on the phosphorylation of
eIF2 at low glucose and had no effect on glucose-stimulated
protein synthesis (Fig. 6b).
Glucose-stimulated Protein Synthesis Is Independent of
mTOR and Parallels an Increase in Ternary Complex Forma-
tion in Islets of Langerhans—To confirm whether the results
obtained in MIN6 cells also occur in primary -cells, islets of
Langerhans were isolated from rats and preincubated for 2 h in
KRB or DMEM supplemented with 2 mM glucose and then
further incubated in the same medium (i.e. KRB or DMEM) for
1 h at either 2 or 20 mM glucose in the presence or absence of
rapamycin. Increasing glucose concentration from 2 to 20 mM
led to a significant increase in [35S]methionine incorporation
into total protein in islets incubated in either KRB or DMEM
(Fig. 7a, panel i). Additionally, glucose-stimulated increases in
the rate of protein synthesis were only partially affected in
KRB and unaffected in DMEM by the addition of rapamycin
(Fig. 7a, panel i). As a control, the phosphorylation of ribosomal
protein S6 was also monitored using a phospho-specific anti-
body to S6 (Ser-235/236) (Fig. 7a, panel ii). As in MIN6 cells, S6
phosphorylation was stimulated at 20 mM glucose in DMEM
but not in KRB, and glucose-stimulated phosphorylation of S6
was completely inhibited by rapamycin (Fig. 7a, panel ii).
To investigate changes in ternary complex availability, rat
islets of Langerhans were infected 48 h with the Ad-ATF4luc
adenovirus. 48 h post-infection, the islets were preincubated for
2 h in KRB containing 2 mM glucose. The cells were then
further incubated for 2 h in KRB supplemented with either 2 or
20 mM glucose, or as control thapsigargin, in the presence of
[35S]methionine during the final hour of treatment. Luciferase
was immunoprecipitated from the cell lysates and separated by
SDS-PAGE, and the incorporation of [35S]methionine into lu-
ciferase was visualized by autoradiography. As expected, thap-
sigargin treatment led to a large increase in the incorporation
of [35S]methionine into luciferase, indicating a large decrease
in the availability of translational ternary complexes. Impor-
tantly, increasing the glucose concentration to 20 mM also led to
a decrease in the incorporation of [35S]methionine into lucifer-
ase, indicating an increase in the availability of translational
ternary complexes (Fig. 7b). The phosphorylation status of
eIF2 was also investigated using a phospho-specific antibody
to eIF2(Ser-51). However, no consistent change in eIF2 phos-
phorylation was observed in response to either glucose or thap-
sigargin (Fig. 7b).
DISCUSSION
Pancreatic -cells are almost unique in their ability to sense
and respond to changes in extracellular glucose, with increases in
glucose concentration leading not only to rapid increases in pro-
insulin synthesis, but also to a rapid increase in the rate of total
protein synthesis. This short term glucose-stimulated protein
synthesis (within 1 h) is almost entirely regulated at the post-
transcriptional level through an increase in the rate of transla-
tion (Refs. 1, 2, 6, and 7 and this report, Fig. 1). However, the one
or more mechanisms by which glucose stimulates an increase in
protein synthesis in pancreatic -cells are poorly understood.
In this report, we demonstrate, in the pancreatic -cell line
MIN6, that glucose stimulates protein synthesis in the pres-
ence or absence of amino acids and that these increases are
FIG. 5. Glucose regulates ternary complex formation in MIN6
cells. MIN6 cells were either mock infected or infected with adenovirus
expressing luciferase downstream of the 5-UTR of ATF4 (Ad-ATF4luc).
After 24 h, MIN6 cells were preincubated in either DMEM or KRB
containing 2 mM glucose for 1 h. Cells were then transferred to the same
medium (DMEM or KRB) containing 2 or 20 mM glucose for 2 h. As a
control, cells were also treated (at 20 mM glucose) with 1 M thapsigar-
gin. During the final hour of treatment, cells were labeled with [35S]me-
thionine. Cells were then lysed, and luciferase was immunoprecipi-
tated. Immunoprecipitated luciferase was run out on SDS-PAGE gels,
and the incorporation of [35S]methionine into luciferase was detected by
autoradiography (IP:Luciferase). Total cell lysates were also separated
on SDS-PAGE and Western blotted (WB) using anti-eIF2 and anti-
phospho eIF2 (Ser-51) (P-eIF2) antisera. Incorporation of [35S]methi-
onine into total protein was expressed as a percentage of the mock
infected 2 mM glucose control. Results presented are representative of
at least three separate experiments.
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likely primarily mediated through an increase in the rate of
initiation of translation (Fig. 2). These increases in protein
synthesis occur via a mechanism that is independent of the
activation of mTOR in the absence of amino acids and only
partially dependent on mTOR in the presence of amino acids.
In contrast, we show that glucose stimulates both the assembly
of the translational ternary complex, eIF2-GTP:Met-tRNAi and
the dephosphorylation of eIF2, both in the absence or pres-
ence of amino acids. Importantly, these changes parallel an
increase in the rate of protein synthesis in response to glucose.
The role of mTOR in glucose-stimulated protein synthesis and
glucose-stimulated changes in ternary complex formation were
confirmed in islets. Therefore, taken together, our data show
that eIF2 phosphorylation is likely to be key in regulating
glucose-stimulated protein synthesis in pancreatic -cells.
However, we cannot definitively conclude that the results ob-
tained in MIN6 cells or islets occur in primary -cells.
It has been reported that glucose stimulates the de-phospho-
rylation of eEF2 in both islets and MIN6 cells between 1 and 10
mM, indicating that glucose may also stimulate an increase in
the rate of elongation (41). Indeed, it has also been reported
that the rate of protein elongation is specifically up-regulated
between 0 and 3.3 mM glucose in islets (42). However, these
increases in the elongation rate are fairly modest and occur
only at these low non-physiological glucose concentrations (42).
Hence, these changes are not thought to play a major role in
glucose-stimulated protein synthesis. Therefore, it is likely
that the primary mechanism by which glucose stimulates pro-
tein synthesis in pancreatic -cells is through an increase in
the rate of initiation.
In a number of other cell types, nutrients such as glucose or
amino acids have been shown to stimulate protein synthesis. In
many of these cases, this has been linked to an increase in the
activity of the protein kinase mTOR (for reviews see Refs.
43–45), which is required for the phosphorylation of both 4E-
BP1 and p70 S6 kinase, two important modulators of protein
FIG. 6. Role of PERK in glucose-stimulated protein synthesis. a, MIN6 cells were preincubated in KRB supplemented with 0.5 mM glucose
for 1 h. The cells were then incubated for a further 1 h at 0.5, 20 mM glucose or 20 mM plus 1 M thapsigargin. After treatment, cell lysates were
separated by SDS-PAGE and Western blotted using anti-phospho-PERK (Thr-980) (P-PERK) and anti-phospho-eIF2 (Ser-51) (P-eIF2) antisera.
b, MIN6 cells were mock-infected, infected with the control adenovirus Ad-Empty.EGFP, or infected with the recombinant adenovirus expressing
a dominant negative form of PERK (Ad-PERKC). 24 h post-infection, the cells were preincubated for 1 h in KRB supplemented with 0.5 mM
glucose prior to further incubation for 1 h in the presence of [35S]methionine in KRB containing 0.5 or 20 mM glucose, or 20 mM glucose and
thapsigargin as a control. Panel i, incorporation of [35S]methionine into total protein expressed as percentage of control (n  3  AvD). Panel ii,
samples of cell lysates were run on a SDS-polyacrylamide gel followed by Western blotting using antisera specific to phospho-eIF2 Ser-51
(P-eIF2) and to total eIF2 as control.
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synthesis. Hyperphosphorylation of 4E-BP1 stimulates its dis-
sociation from eIF4E and the assembly of the eIF4F complex
and hence the rate of initiation from cap-dependent mRNAs
(14–16). The phosphorylation and activation of p70 S6 kinase
leads to the phosphorylation of ribosomal protein S6, which has
been reported to lead to an increase in the rate of initiation of
a specific subset of mRNAs, which have a tract of polypyrimi-
dines in their 5-UTR (46–48). Indeed, in this report, we dem-
onstrate in MIN6 cells that glucose, in the presence of amino
acids, stimulates the phosphorylation of both 4E-BP1 and p70
S6 kinase through a mechanism dependent on mTOR (Fig. 3).
This is in agreement with previous reports demonstrating that
amino acids are required for glucose-stimulated phosphoryla-
tion of 4E-BP1 and p70 S6 kinase in islets and in the pancreatic
-cell line RINm5F (9, 39). We additionally demonstrate that
glucose stimulates the phosphorylation of 4E-BP1 on amino
acid residues Ser-65 and Thr-36/45 (Fig. 3a). Importantly, the
phosphorylation of these residues is known to be critical in
FIG. 7. Glucose-stimulated protein synthesis in islets. a, islets of Langerhans (150 per treatment) were preincubated for 2 h in KRB or
DMEM supplemented with 2 mM glucose. Where indicated, the cells were also pre-treated with 200 nM rapamycin for the last 30 min. The cells
were then incubated for 1 h in the same medium, KRB or DMEM, containing either 2 mM (KRB 2 and DMEM 2) or 20 mM glucose (KRB 20 and
DMEM 20) and [35S]methionine, in the presence or absence of 200 nM rapamycin (Rap). Panel i, incorporation of [35S]methionine into total protein
expressed as percentage of control (KRB 2 mM). Panel ii, samples of cell lysates were run on a SDS-polyacrylamide gel followed by Western blotting
using anti-phospho ribosomal protein S6 (Ser-235/236) antibody (P-S6) and as a loading control, anti-Erk2 antibody. These results are represent-
ative of three separate experiments. b, 48 h before treatment islets of Langerhans (150 per treatment) were mock infected or infected with
Ad-ATF4luc. Following infection, islets were preincubated for 2 h in KRB buffer containing 2 mM glucose. Islets were then incubated for a further
2 h in the same medium at either 2 or 20 mM glucose in the presence of [35S]methionine for the final hour of treatment. Islets were also treated
with 1 M thapsigargin (at 20 mM glucose) as a control. Luciferase was immunoprecipitated from the cell lysates and separated on SDS-PAGE, and
the incorporation of [35S]methionine into luciferase was visualized by autoradiography (IP:Luciferase). Identical total cell lysates were also
separated on a SDS-PAGE and Western blotted (WB) using anti-phospho-eIF2 (Ser-51) and anti-Erk2 antisera as a loading control. Results
presented are representative of three separate experiments.
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stimulating the release of 4E-BP1 from eIF4E (49, 50). Accord-
ingly, we also show that glucose stimulates the release of
4E-BP1 from eIF4E (Fig. 3). Surprisingly, these changes do not
lead to any detectable increase in eIF4F assembly (Fig. 3b).
Therefore, the functional significance of the phosphorylation of
the downstream targets of mTOR is unclear. However, treat-
ment of MIN6 cells or islets with rapamycin, a specific inhibitor
of mTOR, did lead to a partial inhibition of glucose-stimulated
protein synthesis (Figs. 3c and 7a). In the absence of amino
acids, under conditions where there is no detectable phospho-
rylation of the downstream targets of mTOR or any changes in
eIF4F assembly, glucose can still stimulate protein synthesis in
both MIN6 cells and islets (Figs. 3 and 7a). Furthermore, this
glucose-stimulated protein synthesis is unaffected by the addi-
tion of rapamycin in MIN6 cells and only partially affected in
islets (Figs. 3 and 7a). Clearly, these data show that glucose
can stimulate protein synthesis through a mechanism inde-
pendent of mTOR. Therefore, we believe that glucose-stimu-
lated protein synthesis, either in the presence or absence of
amino acids, is likely to be primarily regulated by a mechanism
independent of the activation of mTOR.
An alternative mechanism by which the rate of initiation and
hence protein synthesis could potentially be up-regulated in
response to glucose is through an increase in the availability of
the translational ternary complex. Interestingly, we demon-
strate, both in islets and MIN6 cells, that the availability of the
translational ternary complex is up-regulated at high glucose
concentrations in vivo, either in the presence or absence of
amino acids (Figs. 5 and 7b). It is likely that glucose stimulates
the assembly of the translational complex, at least in part,
through the activation of the guanine nucleotide exchange fac-
tor eIF2B, because eIF2B activity is transiently increased in
response to glucose in rat islets (20). The mechanism by which
eIF2B is regulated by glucose is unknown, but one well char-
acterized mechanism by which eIF2B can be regulated is
through the phosphorylation of eIF2 on Ser-51. In this report,
we demonstrate that eIF2 becomes rapidly dephosphorylated
in response to increasing glucose concentrations in MIN6 cells
and that these changes in eIF2 phosphorylation parallel
changes in glucose-stimulated protein synthesis (Fig. 4, a and
b). Moreover, glucose-stimulated dephosphorylation of eIF2
occurs in both DMEM and KRB (Fig. 4a). In contrast, in islets,
we couldn’t detect any consistent change in the phosphoryla-
tion status of eIF2 in response to glucose (in agreement with
Gilligan et al. (20)) (Fig. 7b). Additionally, we couldn’t detect
any increase in the phosphorylation of eIF2 after treatment
with thapsigargin (an agent known to induce eIF2 phospho-
rylation) (Fig 7b). However, increased glucose concentration
clearly led to an increase in the assembly of the translational
ternary complex, whereas thapsigargin treatment resulted in a
large inhibition of ternary complex formation (Fig. 7b). One
potential reason that could explain why we cannot detect
changes in eIF2 phosphorylation in islets (even after treat-
ment with thapsigargin) is that phosphorylated eIF2 in non-
-cells, or perhaps much more likely, highly phosphorylated
eIF2 in a population of stressed cells, may mask the effects of
glucose or thapsigargin on the phosphorylation of eIF2 in
-cells. Indeed, cells at the center of cultured islets can suffer
from hypoxia, a stress known to induce eIF2 phosphorylation
in other cell types (51). Therefore, given that glucose stimulates
the dephosphorylation of eIF2 in MIN6 cells, we believe that
it is likely that glucose-stimulated assembly of the transla-
tional ternary complex in islets is also mediated by the dephos-
phorylation of eIF2.
Two regulatory subunits of protein phosphatase 1 have been
implicated in eIF2 dephosphorylation. These include
GADD34, whose expression is up-regulated in response to cell
stress (i.e. after a few hours) to stimulate the recovery from the
shut-off of protein synthesis (52, 53) and CReP, which is con-
stitutively active and acts to maintain the basal phosphoryla-
tion state of eIF2 (54). Given the temporal kinetics of eIF2
dephosphorylation in response to glucose in MIN6 cells (Fig.
4c), it is unlikely that this event is regulated through the
up-regulation of GADD34 expression. We believe it is more
likely that these changes in phosphorylation of eIF2 are reg-
ulated through the activity of an eIF2 kinase in combination
with a constitutively active phosphatase.
Glucose starvation is known to stimulate eIF2 phosphoryl-
ation in C6 glial cells (55) and whole mouse pancreata (56). It
is also known that glucose starvation can cause endoplasmic
reticulum stress, hence it was previously speculated that
PERK may phosphorylate eIF2 in response to glucose depri-
vation (57). However, we show that overexpression of a domi-
nant negative mutant of PERK (Ad-PERKC) (29) in MIN6
cells had only a partial effect on the phosphorylation of eIF2
at either low or high glucose concentrations and had no effect
on glucose-stimulated protein synthesis (Fig. 6b). Additionally,
no increase in the phosphorylation of PERK was detected at
low glucose compared with high glucose (Fig. 6a). These data
demonstrate that PERK is unlikely to be the primary eIF2
kinase responsible for eIF2 phosphorylation in response to
low glucose concentration in pancreatic -cells. However, the
eIF2 kinase mGCN2 is regulated by nutrients. For example,
mGCN2 is activated by amino acid starvation (26). Addition-
ally, its yeast orthologue, GCN2, is also activated in response to
glucose starvation (27). However, it has not been demonstrated
that mGCN2 activity is regulated by glucose in mammalian
cells. Nevertheless, it is possible that mGCN2 is the kinase
responsible for the phosphorylation of eIF2 in pancreatic
-cells under conditions of low glucose concentration and this
will be the subject of further investigation.
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